CATIE

Frailty, nerve injury and falls in middle-aged and older HIV-positive people

published: September, 15, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Aging, Social Media, CATIE, General Health, Mental Health, Research, International , Living with HIV, Media, CATIE - HIV and Hep C Info Resource

From CATIE, Sean R. Hosein reports on a U.S. study that links such things as grip strength and gait speed with increased risk of falling.

Frailty, nerve injury and falls in middle-aged and older HIV-positive people

More HIV-positive people are living longer thanks to the use of potent combination anti-HIV therapy (ART). As HIV-positive people enter their middle age and senior years, they will have to grapple with one or more aging-related issues. One issue that can have a large impact on the health and quality of life of older people is falling. Older people who fall can injure themselves, and according to U.S. researchers, such injuries can make pre-existing problems, such as physical inactivity or weak

Ontario researchers find heart attacks occur earlier in people with HIV.

published: September, 12, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, Fitness and Exercise, Research, Health, Media

The researchers found that, on average, HIV-positive people tended to have a heart attack about 15 years before HIV-negative people. From CATIE, Sean R. Hosein reports on the CIHR HIV Trials Network Trial - Reprieve Study.

Ontario researchers find heart attacks occur earlier in people with HIV.

Studies have found that some HIV-positive people are at heightened risk for cardiovascular disease. The reasons for this are not clear but may be due to one or more of the following factors: smoking and/or other substance use elevated inflammation caused by HIV the presence of co-existing health conditions such as elevated blood pressure, type 2 diabetes, obesity exposure to older HIV medicines A number of studies from the U.S. have found that HIV-positive people who had a heart attac

Hepatitis C: A silent killer and story that deserves more attention

published: July, 28, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Hep B and C, CATIE, General Health, Health, Media, CATIE - HIV and Hep C Info Resource

From CATIE on the occasion of World Hepatitis Day (July 28), this report on the current state of the fight against Hepatitis C in Canada.

Hepatitis C: A silent killer and story that deserves more attention

Hepatitis C is a silent killer (people can have it for decades without any symptoms) and a story that is not commonly known in Canada. Yet this virus affects many people, highlights inequities in our health and social systems and is part of an important Canadian story. Canada has a history of being on the forefront of addressing hepatitis C, starting with Dr. Michael Houghton, an internationally recognized microbiologist at the University of Alberta, who was the first to co-discover hepatitis

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

published: May, 15, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, CATIE, Mental Health, Upcoming Events, Health, Living with HIV, Media, CATIE - HIV and Hep C Info Resource

Presented by CATIE and The Network: BC's gbMSM Health Resource.

Webinar: preventing suicide among gay and bisexual men, Tuesday May 30th 10:00am PST

Partners and Collaborators: Register Here! Suicide is the ninth leading cause of death among Canadians, responsible for nearly 4000 deaths each year. While everyone is susceptible to the feelings of hopelessness and despair that precede suicide, gay and bisexual men are 4 times more likely to attempt suicide in their lifetime than heterosexual men. Moreover, the suicide rate among gay and bisexual men in Canada is comparable to the current death toll from HIV/AIDS.  Suicide is preventable.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

published: May, 02, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Research, Health, Treatment, CATIE - HIV and Hep C Info Resource

Sean R. Hosein of CATIE reports on research in Vancouver that attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

Research finds that harm reduction and ART helped to reduce the spread of HIV in Vancouver

In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving an undetectable level of HIV in the blood (viral load) and maintaining it through daily use of ART and regular checkups and laboratory monitori

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

published: April, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Activism, CATIE, Treatment Guidelines -including when to start, General Health, Current Affairs, Health, Treatment, Media, CATIE - HIV and Hep C Info Resource

Those of us in Canada and around the globe who struggle to end the HIV epidemic have lost a friend, mentor and key ally.

CATIE joins in mourning the death of a brilliant scientist and friend – Professor Dr. Mark Wainberg

Dr. Mark Wainberg passed away suddenly earlier this week. He was a brilliant scientist who helped to greatly extend our understanding about HIV and how this virus can develop resistance to treatment.  Dr. Wainberg’s career was centred at McGill University where he was the Director of the McGill AIDS Centre.  He became internationally renowned for the impact that his laboratory had on HIV treatment, as well as for the global impact of his efforts to help make HIV treatment more accessible.

The capsid inhibitor—a new class to enter clinical trials

published: April, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , African, Caribbean and Black, CATIE, Gay Men, General Health, Treatment Guidelines -including when to start, Youth, Women, Health, Sexual Health, International , Treatment, Media, CATIE - HIV and Hep C Info Resource

From CATIE: "This finding suggests that the capsid inhibitor has potential for intermittent dosing in people—perhaps every one or two months."

The capsid inhibitor—a new class to enter clinical trials

Most approved anti-HIV drugs work by interfering with an enzyme and/or protein that is needed by HIV-infected cells to make new viruses. A journey through the cell The capsid is the name given to the proteins that surround HIV’s genetic material. Upon HIV attaching itself to a target cell of the immune system, the virus sends its genetic material (RNA) into the cell. As the genetic material is surrounded by the capsid, it is protected from detection by the cell’s internal sensors. The ca

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017; new drugs, new hope and possible timelines

published: April, 07, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Gay Men, Treatment Guidelines -including when to start, Research, Treatment, Media, CATIE - HIV and Hep C Info Resource

From CATIE, Sean R. Hosein reports on several new drugs that are in varying stages of development.

From the Conference on Retroviruses and Opportunistic Infections (CROI) 2017;  new drugs, new hope and possible timelines

Une version française est disponible ici. At the recent Conference on Retroviruses and Opportunistic Infections (CROI), which took place in Seattle from February 13 to 16, 2017, researchers presented data about new anti-HIV compounds in development, including the following: a new integrase inhibitor – bictegravir a new nuke (NRTI) – code-named GS-9131 a non-nuke (NNRTI) – doravirine a new protease inhibitor – code-named GS-PI1 a capsid inhibitor (a new cla

If you just found out you are HIV-positive...

published: March, 16, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, General Health, Newly Diagnosed, Mental Health, Sexual Health, Health, Treatment, Living with HIV, CATIE - HIV and Hep C Info Resource

CATIE's must-read information for the newly diagnosed.

If you just found out you are HIV-positive...

Finding out you have HIV may be a shock. You do not have to go through this alone: There is help. With ongoing treatment, care and support, HIV can be managed. You can live long and well with HIV. You’ve already taken the first step by getting tested. Now it is important to get care and treatment as soon as you can. 1. HIV can be treated. Talk to the person who gave you your test result about finding a doctor who treats people with HIV. If they cannot give you the name and number of an HI

Research Update: A new HIV primary and secondary prevention continuum

published: March, 13, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Health, Treatment, CATIE - HIV and Hep C Info Resource

For CATIE, Logan Broeckaert reports on a new, cyclical model proposed in the United States designed to help the HIV-negative remain negative.

Research Update: A new HIV primary and secondary prevention continuum

Une version française est disponible ici. The HIV care continuum has become an important way to visualize how well we are doing at ensuring people living with HIV achieve the best possible health and well-being outcomes and minimize the risk of transmission. An undetectable viral load is the key outcome in the HIV care continuum because it is associated with both reduced morbidity and mortality but also a substantially reduced risk for HIV transmission.   A new model, the HIV preve

Views from the front lines: PrEP in Canada

published: March, 01, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , African, Caribbean and Black, Gay Men, CATIE, Treatment Guidelines -including when to start, Women, Treatment, Media, CATIE - HIV and Hep C Info Resource

CATIE spoke to three service providers about PrEP and finds very different conditions in different regions, but a common need for PrEP access.

Views from the front lines: PrEP in Canada

We spoke to three service providers to find their views and insights on how they talk to their clients about PrEP: Holly Taylor, Women's HIV/AIDS Community Development Coordinator, Regional HIV/AIDS Connection, London, Ontario Brook Biggin, Community Education Facilitator, HIV Edmonton; Founder, Edmonton Men’s Health Collective, Edmonton, Alberta Jessica Quijano, Travailleuse de rue, RÉZO, Montreal, Quebec Holly Taylor Are the communities or clients that you work with a

February 28 Webinar Alert: Generations, life course, & gay men’s health: findings from the 2014/2015 National Sex Now Survey

published: February, 27, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Gay Men, CATIE, Research, Health, Sexual Health, Media, Sex and Sexuality , CATIE - HIV and Hep C Info Resource

From CATIE be first to hear findings from the 2014/2015 National Sex Now Survey, the largest survey of sexual minority men in Canada.

February 28 Webinar Alert: Generations, life course, & gay men’s health: findings from the 2014/2015 National Sex Now Survey

Event Date: 28 February 2017, 13:00 EST Register here Presented by: Community-Based Research Centre and BC’s gbMSM Health Network, in partnership with CATIE Over 8,000 participants completed the 2014/15 iteration of the Sex Now survey (SN15), making it the largest survey of sexual minority men in Canada. The theme explored for SN15 was Gay Generations: Life Course and Gay Men’s Health, which provided an unprecedented opportunity to learn more from Canadian men about life course in

Research update: meta-analysis shows PrEP is effective in women with high adherence

published: February, 24, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, Research, Women, Health, International , Treatment, Revolving Door, Guest Authors

From CATIE, Camille Arkell discusses the results of five randomized controlled trials (RCTs) that included women.

Research update: meta-analysis shows PrEP is effective in women with high adherence

Une version française est disponible ici. What do we know about PrEP effectiveness in women? Oral pre-exposure prophylaxis (PrEP) has demonstrated high levels of effectiveness in research conducted among gay men and other men who have sex with men (MSM);1however, research in women has shown mixed results,2,3,4,5,6 leading to concerns that PrEP may be less effective for women. Of the five randomized controlled trials (RCTs) that included women, 2,3,4,5,6 two trials (in women alone) fou

Getting to 90-90-90 requires attention to mental health

published: February, 17, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, CATIE, Mental Health, Research, Health, CATIE - HIV and Hep C Info Resource

CATIE: Studies have found that mental health conditions, including depression and problematic substance use, can, in some cases, increase the risk for non-adherence to ART.

Getting to 90-90-90 requires attention to mental health

Une version française est disponible ici. The Joint United Nations Programme on HIV and AIDS (UNAIDS) has established goals for countries trying to achieve progress in the prevention, care and treatment of HIV infection. Countries and regions are encouraged to strive to meet these goals by the year 2020. The goals can be summarized in the phrase 90-90-90, which stands for the following: 90% of all people living with HIV will know their HIV status 90% of all people with diagnosed HIV

PrEP in Canada: What do we know about awareness, acceptability and use?

published: February, 14, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, African, Caribbean and Black, As Prevention , Gay Men, CATIE, Treatment Guidelines -including when to start, Research, Sexual Health, Health, Treatment, Media, CATIE - HIV and Hep C Info Resource

For CATIE, Camille Arkell reports on the current state of PrEP in Canada.

PrEP in Canada: What do we know about awareness, acceptability and use?

Une version française est disponible ici. Introduction A growing body of evidence tells us that oral pre-exposure prophylaxis (PrEP) is a highly effective strategy for reducing the risk of HIV transmission when used consistently and correctly. In February 2016, Health Canada approved the daily use of the drug Truvada as PrEP, in combination with safer sex practices, to reduce the risk of sexual HIV transmission for people at high risk of HIV infection. This approval was a necessary step

[12 3 4 5  >>